Molecular profiling techniques and bioinformatics in cancer research

European Journal of Surgical Oncology

Volumn 33, Issue 3, 2007, Pages 255-265

  Manning, A T ^a   Garvin, J T ^a   Shahbazi, R I ^a   Miller, N ^a   McNeill, R E ^a   Kerin, M J ^a  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

Bioinformatics; Comparative genomic hybridisation; Digital differential display; DNA microarrays; Molecular profiling; Tissue microarrays

Indexed keywords

BIOINFORMATICS; CANCER GENETICS; CANCER RESEARCH; COMPARATIVE GENOMIC HYBRIDIZATION; DIFFERENTIAL DISPLAY; DNA MICROARRAY; GENE TECHNOLOGY; GENETIC PROCEDURES; INTERMETHOD COMPARISON; MEDICAL LITERATURE; MEDLINE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PUBLICATION; REVIEW; TISSUE MICROARRAY;

COMPUTATIONAL BIOLOGY; DNA, NEOPLASM; GENE EXPRESSION PROFILING; HUMANS; MICROARRAY ANALYSIS; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33947684964     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.09.002     Document Type: Review

References (88)

1. Schena M., Shalon D., Davis R.W., and Brown P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270 5235 (1995) 467-470
2. Duggan D.J., Bittner M., Chen Y., Meltzer P., and Trent J.M. Expression profiling using cDNA microarrays. Nat Genet 21 1 Suppl (1999) 10-14
3. Simon R.M., Korn E.L., McShane L.M., Radmacher M.D., Wright G.W., and Zhao Y. Design and analysis of DNA microarray investigations (2003), Springer, New York
4. Bittner M., Meltzer P., Chen Y., et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406 6795 (2000) 536-540
5. Tanaka T.S., Jaradat S.A., Lim M.K., Kargul G.J., Wang X., and Grahovac M.J. Genome-wide expression profiling of mid-gestation placenta and embryo using a 15,000 mouse developmental cDNA microarray. Proc Natl Acad Sci USA 97 16 (2000) 9127-9132
6. Dobbin K., and Simon R. Sample size determination in microarray experiments for class comparison and prognostic classification. Biostatistics 6 1 (2005) 27-38
7. Berns E.M., van Staveren I.L., Verhoog L., et al. Molecular profiles of BRCA1-mutated and matched sporadic breast tumours: relation with clinico-pathological features. Br J Cancer 85 4 (2001) 538-545
8. Ben-Dor A., Bruhn L., Friedman N., Nachman I., Schummer M., and Yakhini Z. Tissue classification with gene expression profiles. J Comput Biol 7 3-4 (2000) 559-583
9. Radmacher M.D., McShane L.M., and Simon R. A paradigm for class prediction using gene expression profiles. J Comput Biol 9 3 (2002) 505-511
10. West M., Blanchette C., Dressman H., et al. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci USA 98 20 (2001) 11462-11467
11. van 't Veer L.J., Dai H., van de Vijver M.J., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 6871 (2002) 530-536
12. van de Vijver M.J., He Y.D., van't Veer L.J., et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347 25 (2002) 1999-2009
13. Wang Y., Klijn J.G., Zhang Y., et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365 9460 (2005) 671-679
14. Alizadeh A.A., Ross D.T., Perou C.M., and van de Rijn M. Towards a novel classification of human malignancies based on gene expression patterns. J Pathol 195 1 (2001) 41-52
15. McShane L.M., Radmacher M.D., Freidlin B., Yu R., Li M.C., and Simon R. Methods for assessing reproducibility of clustering patterns observed in analyses of microarray data. Bioinformatics 18 11 (2002) 1462-1469
16. Kozian D.H., and Kirschbaum B.J. Comparative gene-expression analysis. Trends Biotechnol 17 2 (1999) 73-78
17. Gray N.S., Wodicka L., Thunnissen A.M., et al. Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. Science 281 5376 (1998) 533-538
18. Marton M.J., DeRisi J.L., Bennett H.A., et al. Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat Med 4 11 (1998) 1293-1301
19. Golub T.R., Slonim D.K., Tamayo P., et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286 5439 (1999) 531-537
20. Alizadeh A.A., Eisen M.B., Davis R.E., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403 6769 (2000) 503-511
21. Bhattacharjee A., Richards W.G., Staunton J., et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 98 24 (2001) 13790-13795
22. Yeoh E.J., Ross M.E., Shurtleff S.A., et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 1 2 (2002) 133-143
23. Dyrskjot L., Thykjaer T., Kruhoffer M., et al. Identifying distinct classes of bladder carcinoma using microarrays. Nat Genet 33 1 (2003) 90-96
24. Perou C.M., Sorlie T., Eisen M.B., et al. Molecular portraits of human breast tumours. Nature 406 6797 (2000) 747-752
25. Gruvberger S., Ringner M., Chen Y., et al. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res 61 16 (2001) 5979-5984
26. Hedenfalk I., Duggan D., Chen Y., et al. Gene-expression profiles in hereditary breast cancer. N Engl J Med 344 8 (2001) 539-548
27. Sorlie T., Perou C.M., Tibshirani R., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98 19 (2001) 10869-10874
28. Ahr A., Karn T., Solbach C., et al. Identification of high risk breast-cancer patients by gene expression profiling. Lancet 359 9301 (2002) 131-132
29. Huang E., Cheng S.H., Dressman H., et al. Gene expression predictors of breast cancer outcomes. Lancet 361 9369 (2003) 1590-1596
30. Sorlie T., Tibshirani R., Parker J., et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100 14 (2003) 8418-8423
31. Paik S., Shak S., Tang G., et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351 27 (2004) 2817-2826
32. Mauriac L., Debled M., and MacGrogan G. When will more useful predictive factors be ready for use?. Breast 14 6 (2005) 617-623
33. Khan J., Wei J.S., Ringner M., et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 7 6 (2001) 673-679
34. Beer D.G., Kardia S.L., Huang C.C., et al. Gene expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 8 8 (2002) 816-824
35. Nguyen D.V., and Rocke D.M. Partial least squares proportional hazard regression for application to DNA microarray survival data. Bioinformatics 18 12 (2002) 1625-1632
36. Rosenwald A., Wright G., Chan W.C., et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346 25 (2002) 1937-1947
37. Bair E., and Tibshirani R. Semi-supervised methods to predict patient survival from gene expression data. PLoS Biol 2 4 (2004) E108
38. Ramaswamy S., Ross K.N., Lander E.S., and Golub T.R. A molecular signature of metastasis in primary solid tumors. Nat Genet 33 1 (2003) 49-54
39. Fan C., Oh D.S., Wessels L., et al. Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 355 6 (2006) 560-569
40. Brazma A., Hingamp P., Quackenbush J., et al. Minimum information about a microarray experiment (MIAME) - toward standards for microarray data. Nat Genet 29 4 (2001) 365-371
41. The R project for statistical computing. http://www.R-project.org.
42. Bioconductor. http://www.bioconductor.org.
43. Gentleman R., Carey V.J., Huber W., Irizarry R.A., and Dudoit S. Bioinformatics and computational biology solutions using R and Bioconductor (2005), Springer, New York
44. Kononen J., Bubendorf L., Kallioniemi A., et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4 7 (1998) 844-847
45. Bubendorf L., Kolmer M., Kononen J., et al. Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays. J Natl Cancer Inst 91 20 (1999) 1758-1764
46. Moch H., Schraml P., Bubendorf L., et al. High throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Pathol 154 4 (1999) 981-986
47. Mucci N.R., Akdas G., Manely S., and Rubin M.A. Neuroendocrine expression in metastatic prostate cancer: Evaluation of high throughput tissue microarrays to detect heterogeneous protein expression. Hum Pathol 31 4 (2000) 406-414
48. Perrone EE, Theoharis C, Mucci NR, et al. Tissue microarray assessment of prostate cancer tumor proliferation in African-American and white men. 2000;92(11):937-39.
49. Schraml P., Kononen J., Bubendorf L., et al. Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res 5 8 (1999) 1966-1975
50. Giltnane J.M., and Rimm D.L. Technology insight: identification of biomarkers with tissue microarray technology. Nat Clin Pract Oncol 1 2 (2004) 104-111
51. van de Rijn M., and Gilks C.B. Applications of microarrays to histopathology. Histopathology 44 2 (2004) 97-108
52. Bertucci F., Salas S., Eysteries S., et al. Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene 23 7 (2004) 1377-1391
53. Dhanasekaran S.M., Barrette T.R., Ghosh D., et al. Delineation of prognostic biomarkers in prostate cancer. Nature 412 (2001) 822-826
54. Camp R.L., Charette L.A., and Rimm D.L. Validation of tissue microarray technology in breast carcinoma. Lab Invest 80 12 (2000) 1943-1949
55. Rimm D.L., Camp R.L., Charette L.A., Costa J., Olsen D.A., and Reiss M. Tissue microarray: a new technology for amplification of tissue resources. Cancer J 7 1 (2001) 24-31
56. Garcia J.F., Camacho F.I., Morente M., et al. Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analysis using tissue microarrays. Blood 101 2 (2003) 681-689
57. Rubin M.A., Dunn R., Strawderman M., and Pienta K.J. Tissue microarray sampling strategy for prostate cancer biomarker analysis. Am J Surg Pathol 26 3 (2002) 312-319
58. Thiellet C. Full speed ahead for tumour screening. Nat Med 4 7 (1998) 767-768
59. Solinas-Toldo S., Lampel S., Stilgenbauer S., et al. Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 20 4 (1997) 399-407
60. Pinkel D., Segraves R., Sudar D., et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20 2 (1998) 207-211
61. Pollack J.R., Perou C.M., Alizadeh A.A., et al. Genomic-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 23 1 (1999) 41-46
62. Snijders A.M., Nowak N., Segraves R., et al. Assembly of microarrays for genome-wide measurement of DNA copy number. Nat Genet 29 3 (2001) 263-264
63. Lucito R., West J., Reiner A., et al. Detecting gene copy number fluctuations in tumour cells by microarray analysis of genomic representations. Genome Res 10 11 (2000) 1726-1736
64. Lucito R., Healy J., Alexander J., et al. Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation. Genome Res 13 10 (2003) 2291-2305
65. Ishkanian A.S., Malloff C.A., Watson S.K., et al. A tiling resolution DNA microarray with complete coverage of the human genome. Nat Genet 36 3 (2004) 299-303
66. Lockwood W.W., Chari R., Chi B., and Lam W.L. Recent advances in array comparative genomic hybridization technologies and their applications in human genetics. Eur J Hum Genet 14 2 (2006) 139-148
67. Kallioniemi A., Kallioniemi O.P., Sudar D., et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumours. Science 258 5083 (1992) 818-821
68. Kiechle M., Jacobsen A., Schwarz-Boeger U., Hedderich J., Pfisterer J., and Arnold N. Comparative genomic hybridization detects genetic imbalances in primary ovarian carcinomas as correlated with grade of differentiation. Cancer 91 3 (2001) 534-540
69. Dent J., Hall G.D., Wilkinson N., Perren T.J., et al. Cytogenetic alterations in ovarian clear cell carcinoma detected by comparative genomic hybridisation. Br J Cancer 88 10 (2003) 1578-1583
70. Aragane H., Sakakura C., Nakanishi M., et al. Chromosomal aberrations in colorectal cancers and liver metastases analyzed by comparative genomic hybridization. Int J Cancer 94 5 (2001) 623-629
71. Nakao K., Shibusawa M., Ishihara A., et al. Genetic changes in colorectal carcinoma tumors with liver metastases analyzed by comparative genomic hybridization and DNA ploidy. Cancer 91 4 (2001) 721-726
72. Reis-Filho J.S., Simpson P.T., Gale T., and Lakhani S.R. The molecular genetic of breast cancer: The contribution of comparative genomic hybridization. Pathol Res Pract 201 11 (2005) 713-725
73. Moore E., Magee H., Coyne J., Gorey T., and Dervan P.A. Widespread chromosomal abnormalities in high-grade ductal carcinoma in situ of the breast. Comparative genomic hybridization study of pure high-grade DCIS. J Pathol 187 4 (1999) 403-409
74. Buerger H., Otterbach F., Simon R., et al. Comparative genomic hybridization of ductal carcinoma in situ of the breast- evidence of multiple genetic pathways. J Pathol 187 4 (1999) 396-402
75. Buerger H., Otterbach F., Simon R., et al. Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes. J Pathol 189 4 (1999) 521-526
76. Buerger H., Mommers E.C., Littmann R., et al. Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution. J Pathol 194 2 (2001) 165-170
77. Aubele M., Mattis A., Zitzelsberger H., et al. Extensive ductal carcinoma in situ with small foci of invasive ductal carcinoma: evidence of genetic resemblance by CGH. Int J Cancer 85 1 (2000) 82-86
78. Loveday R.L., Greenman J., Simcox D.L., et al. Genetic changes in breast cancer detected by comparative genomic hybridisation. Int J Cancer 86 4 (2000) 494-500
79. Hislop R.G., Pratt N., Stocks S.C., et al. Karyotypic aberrations of chromosomes 16 and 17 are related to survival in patients with breast cancer. Br J Surg 89 12 (2002) 1581-1586
80. Greshock J., Naylor T.L., Margolin A., et al. 1-Mb resolution array-based comparative genomic hybridization using a BAC clone set optimized for cancer gene analysis. Genome Res 14 1 (2004) 179-187
81. Schwaenen C., Nessling M., Wessendorf S., et al. Automated array-based genomic profiling in chronic lymphatic leukaemia: development of a clinical tool and discovery of recurrent genomic alterations. Proc Natl Acad Sci USA 101 4 (2004) 1039-1044
82. Kohlhammer H., Schwaenen C., Wessendorf S., et al. Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions. Blood 104 3 (2004) 795-801
83. Benson D.A., Karsch-Mizrachi I., Lipman D.J., Ostell J., Rapp B.A., and Wheeler DL. GenBank. Nucleic Acids Res 30 1 (2002) 17-20
84. Pontius J.U., Wagner L., and Schuler G.D. Unigene: a unified view of the transcriptome. NCBI handbook (2003), NCBI, Bethesda, MD
85. Scheurle D., DeYoung M.P., Binninger D.M., Page H., Jahenzeb B., and Narayanan R. Cancer gene discovery using digital differential display. Cancer Res 60 15 (2000) 4037-4043
86. De Young M.P., Damania H., Scheurle D., Zylberberg C., and Narayanan R. Bioinformatics-based discovery of a novel factor with apparent specificity to colon cancer. In Vivo 16 4 (2002) 239-248
87. Ghadersohi A., and Sood A.K. Prostate epithelium derived Ets transcription factor mRNA is overexpressed in human breast tumours and is a candidate breast tumour marker and a breast tumour antigen. Clin Cancer Res 7 9 (2001) 2731-2738
88. National Cancer Research Institute (NCRI). Strategic framework for the development of cancer research informatics in the UK (2003), NCRI